Explore more
News
CEO of Novo Nordisk, Maker of Weight Loss Drug Wegovy
Digest more
When considering a weight loss medication — or any medication — it’s normal to wonder when the effects will kick in.
Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly.
A trial was conducted comparing weight loss medications Zepbound and Wegovy. Results from the trial found that participants ...
Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...
Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss ...
True or False: Pooled trial data showed that rheumatoid arthritis patients taking tofacitinib (Xeljanz) were less likely to ...
A new study shows that people Zepbound lost about 50% more weight than those using Wegovy. It was the first head-to-head ...
One weight loss injection has been branded more effective than another, after scientists carry out the first ever ...
The head-to-head examination of these weight loss drugs provides doctors with 'robust' data on their effectiveness.
Obesity has long been one of America's most persistent and complex public health challenges. Despite the rise and fall of countless weight-loss fads and miracle diets, millions of people still find ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback